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PENGHASILAN RETIKULOSIT DARIPADA SEL STEM 
HEMATOPOITIK/SEL PROGENITOR CD34+ DARIPADA DARAH 
PERIFERI MANUSIA UNTUK ASAI JANGKITAN Plasmodium knowlesi 




Retikulosit adalah sel perumah khusus kepada Plasmodium knowlesi, 
parasit malaria manusia kelima yang telah dikenal pasti. Namun, retikulosit yang sedia 
ada untuk pengkulturan P. knowlesi in vitro dibatasi oleh bilangan retikulosit yang 
terhad dalam peredaran darah periferi manusia (PB). Oleh itu, sel stem 
hematopoitik/sel progenitor CD34+ (HSPC) yang terhasil daripada PB manusia 
mempunyai potensi proliferatif yang tinggi telah digunakan dalam kajian ini sebagai 
sumber bagi menghasilkan bekalan retikulosit yang mencukupi untuk asai jangkitan 
P. knowlesi secara in vitro. HSPC CD34+ diperkembangkan selama 5 hari di dalam 
media bebas serum yang ditambah bersama sitokin pengembangan dan faktor 
pertumbuhan. HSPC CD34+ yang telah diperkembangkan kemudian dikultur selama 
14 hari bersama sitokin penyokong sel eritroid untuk pembezaan kepada keturunan 
eritroid bagi penghasilan retikulosit. Pencirian kematangan HSPC CD34+ kepada 
retikulosit dilakukan dengan melihat pengekspresan penanda permukaan sel dan juga 
morfologi sel yang melalui pembezaan. Kecenderungan retikulosit yang terhasil 
terhadap jangkitan oleh P. knowlesi dan P. falciparum (sebagai kawalan) ditentukan. 
Setelah 5 hari menjalani proses pengembangan, jumlah populasi sel meningkat kira-
kira 2.10 ± 0.10 kali ganda dalam kultur yang mengandungi HSPC CD34+. Komitmen 
HSPC CD34+ kepada keturunan eritroid dapat dikesan melalui ekspresi penanda 
xviii 
 
CD36/CD71 yang lebih tinggi dan ekspresi penanda lain yang rendah seperti CD34 
dan CD45 pada hari ke 11. Penurunan ekspresi penanda CD36/CD71 pada hari ke 14 
menunjukkan normoblas telah matang menjadi retikulosit. Analisis morfologi 
menunjukkan kemunculan proeritroblast, sebuah sel nukleasi yang besar pada hari ke 
8. Perkembangan proeritroblast menjadi normoblas telah diperhatikan pada hari ke 11 
melalui ukuran sel yang semakin mengecil. Sel-sel enukleasi yang mengandungi 
sekurang-kurangnya tiga titik asid ribonukleik (RNA) berwarna biru kresil telah 
dikenal pasti sebagai retikulosit dan mencapai jumlah maksimumnya sebanyak 30.00 
± 1.76% pada hari ke 14. Asai jangkitan menunjukkan bahawa P. knowlesi menjangkiti 
retikulosit yang dihasilkan daripada HSPC CD34+ dan disahkan melalui pewarnaan 
Giemsa pada 24 jam selepas inokulasi, namun dengan indeks jangkitan yang rendah, 
1.20 ± 0.33%. Manakala, P. falciparum menjangkiti retikulosit yang dihasilkan 
daripada HSPC CD34+ dengan lebih berkesan telah diperhatikan pada 41 jam selepas 
inokulasi dengan indeks jangkitan 2.60 ± 0.11%. Kesimpulannya, HSPC CD34+ yang 
terhasil daripada PB manusia boleh menjadi sumber yang berpotensi bagi 





GENERATION OF RETICULOCYTES DERIVED FROM HUMAN 
PERIPHERAL BLOOD CD34+ HAEMATOPOIETIC STEM/PROGENITOR 




Reticulocytes are specialised host cells for Plasmodium knowlesi, the 
fifth identified human malaria parasite. Yet, the availability of reticulocytes for P. 
knowlesi in vitro culture is restricted by the limited number of circulating reticulocytes 
in human peripheral blood (PB). Therefore, human PB-derived CD34+ haematopoietic 
stem/progenitor cells (HSPCs) with high proliferative potential were utilised in the 
present study as a source to generate sufficient supply of reticulocytes for P. knowlesi 
in vitro invasion assay. CD34+ HSPCs were expanded for 5 days in serum-free medium 
supplemented with expansion cytokines and growth factors. Expanded CD34+ HSPCs 
were then cultured with erythroid-supporting cytokines for 14 days for differentiation 
towards erythroid lineage to produce reticulocytes. The maturation of CD34+ HSPCs 
into reticulocytes was characterised by the expression of cell surface markers as well 
as the morphology of cells undergoing differentiation. The susceptibility of generated 
reticulocytes to invasion by P. knowlesi and P. falciparum (as a control parasite) was 
determined. After 5 days of expansion, the total cell population increased 
approximately 2.10 ± 0.10-fold in a culture initiated with CD34+ HSPCs. The 
commitment of CD34+ HSPCs towards the erythroid lineage was identified through a 
high expression of CD36/CD71 on day 11 and a decrease in expression of CD34 and 
CD45. Down regulation of CD36/CD71 expression on day 14 indicated that the 
maturation of normoblasts into reticulocytes. The morphological analysis revealed the 
xx 
 
presence of proerythroblasts, a large nucleated cell on day 8. The progression of 
proerythroblasts into normoblast was observed on day 11 by a decrease in cell size. 
Enucleated cells with at least three dots of cresyl blue ribonucleic acid (RNA) were 
recognised as reticulocytes and reached its maximum at 30.00 ± 1.76% on day 14. The 
invasion assay showed that P. knowlesi invaded CD34+ HSPC-derived reticulocytes, 
which was confirmed by Giemsa stained observations at 24-hour post-inoculation, 
however, with lower invasion index, 1.20 ± 0.33%. Meanwhile, P. falciparum 
efficiently invaded CD34+ HSPC-derived reticulocytes which was observed at 41-hour 
post-inoculation with an invasion index of 2.60 ± 0.11%. In conclusion, human PB-
derived CD34+ HSPCs could be considered as a potential source to generate 







1.1 Background of the study 
 
Malaria is one of the public health threats caused by protozoa of the genus 
Plasmodium. According to the World Malaria Report 2019, approximately 228 million 
cases of malaria occurred in 2018 resulting in over 405 000 deaths (World Health 
Organization (WHO), 2019a). P. falciparum is responsible for most of the malaria 
cases and deaths, which accounted for 99.7% cases in the African region, 71% cases 
in the Eastern Mediterranean region and 50% cases in the Southeast Asia region in 
2018 (WHO, 2019a).  
 
Many efforts have been focused on the treatment and control of this 
malaria parasite because of the high mortality and severity that P. falciparum could 
cause. In comparison to P. falciparum, another four types of human malaria parasites, 
P. vivax, P. ovale, P. malariae and P. knowlesi which are less virulent, were less 
studied (Woodford et al., 2020). Poor understanding of the biology and pathogenesis 
of these parasites have partly become the major challenge towards a progressive effort 
to eliminate malaria disease (Barber et al., 2017; Yman et al., 2019; Woodford et al., 
2020).  
 
A major outbreak of P. knowlesi in human has recently been recorded in 
Southeast Asia (WHO, 2017). Knowlesi malaria is transmitted as a zoonosis from 
long-tailed (Macaca fascicularis) and pig-tailed macaques (Macaca nemestrina) as the 
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natural hosts (Moyes et al., 2016; WHO, 2017). In Malaysia, P. knowlesi was reported 
to be the most predominant species causing malaria in humans (Cooper et al., 2020). 
Most of the P. knowlesi cases were reported in Sabah and Sarawak of Malaysian 
Borneo and other states in Peninsular Malaysia including Kelantan, Pahang, Selangor 
and Perak (Yusof et al., 2014; WHO, 2017). P. knowlesi infections can cause severe 
disease as seen in infections with P. falciparum and are potentially fatal due to its short 
intraerythrocytic cycle (~24 hours) (Rajahram et al., 2019). Therefore, knowlesi 
malaria has been one of the emergencies of healthcare (Chong et al., 2017). 
 
Despite its public health importance, research on P. knowlesi still lags 
behind that of P. falciparum partly due to the lack of a continuous in vitro culture 
system. Several attempts have been made to maintain P. knowlesi in vivo in rhesus 
macaques (M. mulata) (Lapp et al., 2015; Amir et al., 2016) and in vitro using rhesus 
macaque erythrocytes (Moon et al., 2016; van Schalkwyk et al., 2019). However, these 
attempts consumed expensive costs for daily animal care as well as restricted research 
to laboratories with access to primate facilities (Moon et al., 2013; Grüring et al., 
2014). P. knowlesi also has difficulty to adapt to an in vitro culture using human 
erythrocytes as it specificity only invade the immature erythrocytes known as 
reticulocytes (Lim et al., 2013; Grüring et al., 2014). Reticulocytes are short-lived 
(~24 hours) and represent only 0.5-1% of the circulating erythrocytes. This poses a 
challenge to accumulate enough numbers of these cells for establishment of an in vitro 
P. knowlesi culture (Noulin et al., 2014).  
 
Reticulocytes can be enriched from sources that have high concentrations 
of these cells such as peripheral blood (PB) of haemochromatosis patients (Shaw-
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Saliba et al., 2016; Prajapati et al., 2019) and human umbilical cord blood (UCB) 
(Russell et al., 2011; Borlon et al., 2012). The challenge remains whereby these 
sources are not widely available. A density centrifugation technique using percoll has 
also been used to enrich reticulocytes; however, this procedure involves invasive 
washing steps that would affect the efficiency of parasites to invade the cells (Noulin 
et al., 2012; Malleret et al., 2015). Therefore, an alternative approach to generate 
sufficient numbers of reticulocytes is needed. 
 
Haematopoietic stem/progenitor cells (HSPCs) can be expanded in vitro 
and, under appropriate conditions, can be differentiated into the erythroid lineage to 
produce reticulocytes (Fernandez-Becerra et al., 2013; Furuya et al., 2014; Noulin et 
al., 2014; Kupziq et al., 2017). CD34+ HSPC-derived reticulocytes have previously 
been used for culturing P. vivax, a human malaria parasite phylogenetically related to 
P. knowlesi; but, no studies have been done to culture P. knowlesi with these cells. 
High expansion and isolation potential of CD34+ HSPCs derived from human PB 
might contribute to a great interest towards the in vitro culture and generation of 
reticulocytes for P. knowlesi invasion. Therefore, the present study aimed to generate 
an in vitro differentiation system to produce reticulocytes from human PB-derived 
CD34+ HSPCs for invasion by P. knowlesi in vitro.  
 
1.2 Problem statement 
 
The biology of P. knowlesi remains poorly understood partly due to the 
lack of a robust in vitro culture system. The macaque blood and serum have been 
previously used for the establishment of this parasite culture system (Amir et al., 2016; 
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Moon et al., 2016; van Schalkwyk et al., 2019); however, such system required 
laboratories with access to macaque facilities (Lim et al., 2013; Grüring et al., 2014). 
A continuous effort has been made to grow P. knowlesi exclusively in human blood 
(Kocken et al., 2009) but unsuccessful since P. knowlesi has a preference towards 
human reticulocytes (Lim et al., 2013; Grüring et al., 2014). In addition to this, the 
availability of reticulocytes is tremendously limited, which one way of having the 
access to are from sources that have higher concentrations of these cells such as UCB 
(Russell et al., 2011; Borlon et al., 2012). The difficulty in gaining access of blood 
from UCB has become a major drawback. 
 
1.3 Rationale of the study 
 
Therefore, a generation of reticulocytes derived from human PB-derived 
CD34+ HSPCs was addressed in the present study. The optimum number of 
reticulocytes produced for P. knowlesi invasion, the phenotype (CD36/CD71) and 
morphology of the generated reticulocytes were evaluated by using haemocytometer, 
flow cytometry and brilliant cresyl blue staining, respectively. The biological 
functionality of the generated reticulocytes was determined by its ability to sustain P. 
falciparum infection prior to invasion by P. knowlesi. The transferrin receptor, CD71 
was identified as one of the important receptors for malaria parasite invasion. The 
generated reticulocytes that expressed CD71 might be a potential candidate for malaria 
parasite entry as well as for a successful invasion by P. knowlesi. Therefore, a 
successful establishment of a P. knowlesi in vitro culture would provide an ideal model 




1.4 Objectives of the study 
 
1.4.1 General objective 
 
The overall goal of this study was to generate and characterise reticulocytes 
differentiated from human PB-derived CD34+ HSPCs for P. knowlesi invasion assay. 
 
1.4.2 Specific objectives 
 
1) To isolate and characterise the isolated CD34+ HSPCs from peripheral 
blood mononuclear cells (PBMCs) using flow cytometry 
2) To expand, differentiate and characterise the reticulocytes derived from 
CD34+ HSPCs  
3) To determine the invasion of reticulocytes derived from CD34+ HSPCs by 
P. knowlesi and P. falciparum in vitro 
 
1.5 Experimental design 
 
The flow chart of the study is shown in Figure 1.0. Firstly, PBMCs were 
isolated from the PB of healthy donors by using a density gradient centrifugation. The 
isolation of CD34+ HSPCs was performed by positive selection of CD34-expressing 
cells by using magnetic-activated cell sorting (MACS) microbeads. The purity of the 




The isolated CD34+ HSPCs were expanded in a serum-free expansion 
medium II (SFEM II) combined with an expansion cocktail, a set of cytokines and 
growth factors, to increase the cell numbers and to preserve the stemness properties of 
the cells. For reticulocyte production, the expanded CD34+ HSPCs were induced into 
erythroid differentiation using serum-free differentiation media supplemented with 
erythroid lineage-specific cytokines. This allows differentiated cells to mature into 
well-characterised erythroid cells producing reticulocytes in vitro. The generated 
reticulocytes were characterised by determining the expression of cell surface markers 
and identifying the morphology of the cells.  
 
P. knowlesi-infected blood samples were obtained from patients who were 
confirmed positive for malaria infection and admitted to Hospital Gua Musang and 
Hospital Kuala Krai, Kelantan. The cryopreserved P. knowlesi clinical isolates were 
thawed and parasitaemia as well as stage of the parasite were determined prior to 
culture. After that, the unsynchronised cultures of P. knowlesi isolates were incubated 
with generated reticulocytes for the invasion assay. Meanwhile, ring stages of P. 
falciparum (control) were synchronised by sorbitol treatment to obtain highly 
synchronous cultures of mature schizonts at high purity after 24 hours of cultivation. 
By using the MACS method, the mature schizonts of P. falciparum were separated 
from the uninfected erythrocytes and then added with the generated reticulocytes. The 
parasitaemia of P. knowlesi-infected reticulocytes and P. falciparum-infected 
reticulocytes at 24-hour and 41-hour post-inoculation was determined by Giemsa stain, 
respectively. The susceptibility of reticulocytes to invasion by P. knowlesi and P. 






Figure 1.0:  The flowchart of the study 
Generation of reticulocytes 
Isolation of CD34+ HSPCs from PBMCs 
Expansion of CD34+ HSPCs 
Differentiation of CD34+ HSPCs into reticulocytes 
Characterisation of reticulocytes 
Assessment of cell surface markers 
Morphological observation of 
nucleated and enucleated cells 
Invasion assays 
Cultivation of P. knowlesi isolates and P. falciparum 
Invasion of generated reticulocytes with unsynchronised P. knowlesi 
isolates and synchronised mature schizonts of P. falciparum 







2.1 Overview of malaria 
 
Malaria persists as an undiminished worldwide problem and remains as 
the most significant parasitic disease infecting humans (White et al., 2013; Ashley et 
al., 2018). Previously, the disease was presumed to originate from fetid environments, 
hence the name mal aria (bad air) (Talapko et al., 2019). In 1880, Laveran, a French 
army surgeon revealed that the protozoan parasites from the Plasmodium genus are the 
main culprit of malaria (Talapko et al., 2019). Later in 1897, Ross, a British army 
surgeon discovered that the malaria parasites were transmitted to human through the 
bites of infected female Anopheles mosquitoes (O’Donoghue, 2017; Ashley et al., 
2018). There are five Plasmodium species that infect humans namely P. falciparum, 
P. vivax, P. ovale, P. malariae and P. knowlesi. P. falciparum is the deadliest parasite 
responsible for most malaria cases and deaths worldwide while P. knowlesi is a 
zoonotic parasite emerges from some parts of Southeast Asia (White et al., 2013; 
Ashley et al., 2018; Hocking et al., 2020). In this study, the invasion index of both P. 
knowlesi and P. falciparum on reticulocytes were investigated. 
 
2.1.1 Distribution of malaria 
 
An estimated 3.3 billion people in 91 countries were at risk of contracting 
malaria in 2018 (WHO, 2019a). In the same year, approximately 228 million cases of 




region accounted for the highest malaria cases (94%) followed by the Southeast Asia 
(3.4%) and Eastern Mediterranean (2.1%) regions (Figure 2.1) (WHO, 2019a). Most 
malaria cases were caused by P. falciparum and reported predominantly in the African 
region. Outside of the African region, P. vivax is mostly distributed in the Americas, 
Eastern Mediterranean and Southeast Asia regions, whilst P. knowlesi is reported as 
the major cause in most endemic areas in Southeast Asia (WHO, 2019b). 
 
According to the World Malaria Report 2019, Malaysia has successfully 
eliminated the indigenous transmission of all human malaria parasites such as P. 
falciparum, P. vivax, P. ovale and P. malariae for the first time in 2018 (WHO, 2019b). 
However, the zoonotic P. knowlesi malaria cases increase of from 1 600 to > 4 000 
cases between 2016 and 2018 with 12 deaths in 2018 (WHO, 2019a). P. knowlesi cases 
were mostly recorded in Malaysian Borneo and other states in Peninsular Malaysia 
(Cooper et al., 2019). 
 
2.1.2 Clinical symptoms of malaria 
 
Fever is the clinical hallmark of malaria. After 7-8 days of infection, 
prodromal symptoms of the disease such as headache, fatigue and abdominal discomfort 
may develop followed by fever, chills, nausea, vomiting and malaise (WHO, 2015). As 
the infection progresses, periodic febrile paroxysms starting with a cold stage (15-60 
minutes) that is characterised by chills and extreme shaking. This progresses to a hot 
stage (2-6 hours) in which the infected person may have fever (sometimes reaching 
41°C), nausea and vomiting (Ansong et al., 2020). At a terminal sweating stage (2-4 






Figure 2.1: Malaria burden worldwide in 2000 and the status by 2018  
Countries with zero indigenous cases over at least the past three consecutive years are considered as no longer endemic in 2018. China and El 
Salvador reported zero indigenous cases for the second consecutive years. Meanwhile, Malaysia, Iran and Timor-Leste reported zero indigenous 
cases for the first time. However, Malaysia is facing increasing cases of zoonotic malaria due to P. knowlesi. Adapted from World Malaria Report 
2019 (WHO, 2019a).
One or more indigenous cases 
Zero cases in 2017-2018
Zero cases in 2018
Zero cases (>3 years) in 2018






Paroxysms occur when the infected erythrocytes ruptured, releasing 
thousands of merozoites into the bloodstream (Phillips et al., 2017). The intervals 
between febrile paroxysms depend on the period of the intraerythrocytic cycle of the 
parasites. The intraerythrocytic cycle of P. falciparum, P. vivax and P. ovale occurs 
every 48 hours indicating that the febrile paroxysm occurs every third day of infection 
(tertian fever) (Ansong et al., 2020). In P. malariae infection, the febrile paroxysm is 
separated by the 72-hour intervals (quartan fever). P. knowlesi requires 24 hours to 
complete the intraerythrocytic cycle, which results in a unique quotidian type of fever 
pattern that is different from all human malaria parasites. 
 
2.2 The life cycle of the malaria parasites 
 
2.2.1 The sexual cycle of the malaria parasites 
 
All Plasmodium species are characterised by a complex life cycle that 
involves a sexual cycle in a female Anopheles mosquito and an asexual cycle in a 
vertebrate or a human host (Figure 2.2) (Cowman et al., 2016). The sexual cycle begins 
when a mosquito ingests the sexual stages called gametocytes from an infected host 
during a blood meal. In the mosquito’s mid gut, the microgametocytes (males) and 
macrogametocytes (females) differentiate into microgametes and macrogametes, 
respectively before fusing to form zygotes (Figure 2.2A) (Bennink et al., 2016). The 
zygotes develop into motile ookinetes that penetrate the mid gut epithelium and 
develop into oocysts. Oocysts enlarge and rupture to release sporozoites that migrate 
to the mosquito’s salivary gland, rendering the mosquito infectious to a vertebrate or a 





Figure 2.2: The malaria parasite’s life cycle 
A complete malaria parasite’s life cycle comprises a sexual cycle within a female 
Anopheles mosquito and an asexual cycle within an intermediate host (human or 
vertebrate). (A) The sexual cycle starts when a mosquito takes up male gametocytes 
(microgametes) and female gametocytes (macrogametes), leading to a production of 
infective sporozoites. (B) During a blood meal, sporozoites are released by the infected 
mosquito to the bloodstream and travel to the liver, initiating the asexual 
exoerythrocytic cycle. The parasite grows and differentiates in the hepatocyte to form 
a merozoite-containing schizont. The released merozoites after the rupture of schizont 
travel in the blood circulation, initiating the asexual intraerythrocytic cycle. (C) The 
merozoites invade erythrocytes and develop into the ring, trophozoite and schizont 
stages. The released merozoites continue to invade new erythrocytes. Some parasites 
commit to form the sexual stages of gametocytes to be ingested by a mosquito to 
complete the parasite’s life cycle. Modified from Favuzza et al. (2020). 
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2.2.2 The asexual cycle of the malaria parasites 
 
Infection in humans starts when an infected mosquito injects sporozoites 
into the bloodstream. The sporozoites travel to the liver and invade hepatocytes to 
initiate the exoerythrocytic cycle (Figure 2.2B). The infection during this stage is non-
pathogenic and clinically asymptomatic. The parasite multiplies and develops into a 
multinucleated schizont. The ruptured hepatic schizont releases thousands of 
merozoites into the bloodstream, initiating the intraerythrocytic cycle (Figure 2.2C) 
(Ansong et al., 2020). The parasite invades the erythrocyte and develops through the 
ring, trophozoite and schizont stages. The parasite feeds on the haemoglobin and 
produces haemozoin, which is the product of haemoglobin digestion (Ansong et al., 
2020). The schizont stage parasite then ruptures, releasing merozoites to invade new 
erythrocytes, completing the intraerythrocytic cycle. The intraerythrocytic cycle is 
responsible for the clinical symptoms attributable to the disease. The repetitive rounds 
of invasion, growth and division occur in 24 hours for P. knowlesi, 36-48 hours for P. 
falciparum, 48 hours for P. vivax and P. ovale or 72 hours for P. malariae (Figure 2.3). 
P. knowlesi has the shortest intraerythrocytic cycle compared to the other human 
malaria parasites, leading to rapid increase of parasitaemia levels causing a potentially 














Figure 2.3: The intraerythrocytic development of the malaria parasites 
(A) The 24-hour intraerythrocytic development of P. knowlesi shows the parasite 
develops into the ring (1-4 hours post-invasion), trophozoite (10-14 hours post-
invasion) and schizont stages (19-24 hours post-invasion). The schizont undergoes 
segmentation, producing merozoites to invade new erythrocyt. (B) In P. falciparum, 
P. vivax and P. ovale, the intraerythrocytic development occurs for 48 hours. The 
parasite at a ring stage grows for ~24 hours before developing into a trophozoite (25-





2.3 Overview of P. knowlesi 
 
P. knowlesi is a malaria parasite originally found in long-tailed (Macaca 
fascicularis) and short-tailed (Macaca nemestrina) macaques in Southeast Asia. This 
parasite has recently been identified as the important cause of malaria in human (Brock 
et al., 2019). Knowlesi malaria is transmitted among macaques and humans by the 
Anopheles leucosphyrus group of mosquitoes (Moyes et al., 2016). Human 
encroachment into the wildlife habitats and environmental changes contribute towards 
the emergence and transmission of this zoonotic disease (Fornace et al., 2019). 
 
2.3.1 A brief history of the P. knowlesi discovery 
 
P. knowlesi was first seen by an Italian physician, Franchini in 1927 in the 
blood of M. fascicularis (Figure 2.4) (Brieger, 2016; Franchini, 1927). A few years 
later, the parasite was observed by Campbell and Napier in the blood of M. fascicularis 
imported from Singapore to the Calcutta School of Tropical Medicine, India (Napier 
and Campbell, 1932). The infected macaque was then given to Das Gupta who 
maintained the parasite via sub-passage. Knowles and Das Gupta characterised the 
intraerythrocytic stages of the parasite and transmitted the parasite to humans 
(Knowles and Gupta, 1932). Later, Sinton and Mulligan confirmed the morphology of 
the parasite and the 24-hour intraerythrocytic cycle, confirming the parasite as a new 
species (Sinton and Mulligan, 1933). The parasite was named P. knowlesi in honour 








Figure 2.4: A brief history of P. knowlesi discovery 





Following the discovery of P. knowlesi, the parasite was extensively used 
as a pyretic agent to treat neurosyphilis (van Rooyen and Pile, 1935). However, the 
treatment discontinued after few years due to the increased virulence following 170 
serial passages of the parasite in the patients (Ciuca et al., 1955). Despite the first case 
of a naturally acquired human infection with P. knowlesi was reported in 1965 (Chin 
et al., 1965), it was only in 2004 that a large case of knowlesi malaria in Kapit, Sarawak 
was revealed by Singh and his colleagues (Singh et al., 2004; Lubis et al., 2017; 
Gamalo et al., 2019). This is due to the morphologically misdiagnosed of P. knowlesi 
cases as P. malariae or P. falciparum infections.  
 
2.3.2 Clinical symptoms of knowlesi malaria 
 
Most clinical P. knowlesi cases are less complicated with non-specific 
febrile illness and thrombocytopenia (Grüring et al., 2014); however, some patients 
may experience high parasite counts in the blood leading to the development of a 
complicated and fatal disease (Singh and Daneshvar, 2013; Cox-Singh and Culleton, 
2015). In clinical studies, high parasitaemia in P. knowlesi-infected patients correlates 
with the disease severity, which is similar to cases with P. falciparum (Cox-Singh and 
Culleton, 2015). The main difference is falciparum malaria can cause cerebral malaria 
characterised by coma (Yusuf et al., 2017) whereas this feature is absent in knowlesi 
malaria (Barber et al., 2017; Grigg et al., 2018). This suggests that these parasites 






2.3.3 Diagnosis of knowlesi malaria 
 
Each human malaria parasite has distinct morphological characteristics 
can be distinguished by microscopy for disease detection and species identification 
(Mathison and Pritt, 2017; Amir et al., 2018). Due to sequestration of late trophozoites 
and schizonts of P. falciparum-infected erythrocytes in the microcirculation, only ring 
forms, early trophozoites or gametocytes were observed in the PB smears of patients 
(Barber et al., 2017; Mathison and Pritt, 2017). As for P. malariae, all intraerythrocytic 
stages were observed in the blood smears especially trophozoites that appear as band 
forms. However, misidentification does occur that hinders rapid diagnosis and proper 
treatment. The band forms of P. knowlesi are commonly misdiagnosed as P. malariae 
or as P. falciparum if ring forms are present (Figure 2.5) (Grüring et al., 2014; Barber 
et al., 2016). 
 
Molecular detection methods have been developed for more accurate 
identification of malaria parasites compared to microscopy (Amir et al., 2018; 
Mwanga et al., 2019). Real-time polymerase chain reaction (RT-PCR) assays have an 
advantage over nested PCR assays and the single-step PCR assays by providing more 
rapid identification (Britton et al., 2016). The assays are more likely to be available in 
the diagnostic laboratories in developed countries or referral laboratories in the 
developing countries due to their relatively high costs. Immunochromatographic rapid 
diagnostic tests (RDTs) have also been developed for detection of malaria. RDTs are 
useful in rural areas whereby electricity supply is limited and in laboratories for 
laboratory technologists that are unfamiliar with malaria microscopic detection. 






Figure 2.5: Morphology of P. knowlesi, P. falciparum and P. malariae in 
Giemsa-stained thin blood smears 
Early trophozoites of P. knowlesi resemble ring forms of P. falciparum: double 
chromatin dots and multiple infected erythrocytes. While late and mature trophozoites, 
schizonts and gametocytes of P. knowlesi in human infections were usually 




P. falciparum P. malariae 




of the first RDT, namely OptiMAL-IT that could detect P. knowlesi, could wrongly 
identify it as P. falciparum due to antibody cross-reactivity (Amir et al., 2018; Zaw 
and Lin, 2019). While, other RDTs such as BinaxNow, Paramax-3 and Entebe Malaria 
Cassette show low sensitivity and cross-reactivity between  P. vivax and P. knowlesi. 
Thus, this could lead to misdiagnosis of malaria species which can affect drug 
administration to the patients (Amir et al., 2018). 
 
2.3.4 Treatment of knowlesi malaria 
 
Immediate diagnosis and introduction of effective treatment play a crucial 
role in reducing morbidity and mortality caused by P. knowlesi. In Malaysia, the 
standard treatment regime for uncomplicated P. knowlesi infections is chloroquine 
(Ministry of Health, 2013; Amir, 2016). According to the WHO recommendations for 
the treatment of malaria, different combinations of artemisinin-based combination 
therapies (ACTs) (i.e artemether-lumefantrine) have been successfully used to treat 
uncomplicated knowlesi malaria (WHO, 2015). The ACTs are the first line treatment 
for knowlesi malaria in Malaysia (Ministry of Health, 2013). Intravenous artesunate 
has also been recommended for treatment of severe knowlesi malaria (Ministry of 
Health, 2013; Ansong et al., 2020). The ACTs are however not recommended for 
pregnant women in their first trimester (Amir, 2016). Treatment with primaquine is 
not recommended since P. knowlesi does not relapse from hypnozoites, a dormant liver 
stage (Ansong et al., 2020). There were no antimalarial resistant strains reported for 





2.3.5 P. knowlesi as an experimental model for malaria 
 
P. knowlesi offers many advantages as an ideal model for malaria study 
(Grüring et al., 2014). The strain first investigated in rhesus macaques (M. mulatta) in 
which the parasite produces fulminating infection (Collins et al., 1967; Pasini et al., 
2018). Before in vitro culture of P. falciparum was established, the rhesus infections 
provided a source of highly synchronous parasites for studies. The rhesus malaria 
models were proven invaluable for malaria vaccine development (Butcher and 
Mitchell, 2018; Grüring et al., 2014), antigenic variation (Galinski et al., 2018; Pasini 
et al., 2018) and parasite invasion studies (Amir et al., 2016; Moon et al., 2016). P. 
knowlesi and P. vivax are evolutionarily closely related (Mohring et al., 2019). 
Therefore, the P. knowlesi animal model provides insights into the unique aspects of 
the P. vivax biology and the discovery of diagnostic tools, antimalarial drugs and 
vaccines (Grüring et al., 2014; Noulin et al., 2014).  
 
The invasion of P. knowlesi is coordinated by merozoite protein families 
that mediate specific and direct interactions with the receptors on the surface of 
erythrocyte (Lim et al., 2017). There are two types of merozoite protein families 
namely the reticulocyte binding-like protein (RBL) family and the Duffy binding-like 
protein (DBL) family (Divis et al., 2015; Lim et al., 2017). In P. knowlesi, the RBL 
family expressed on merozoites are known as normocyte binding proteins, PkNBPXa 
and PkNBPXb (Moon et al., 2016; Lim et al., 2017). Whereas in P. vivax, the RBL 
family named reticulocyte binding proteins, PvRBP1 and PvRBP2 are responsible for 





P. knowlesi and P. vivax are known to interact with the Duffy antigen 
receptor for chemokines (DARC) to invade Duffy-positive human erythrocytes. There 
was no invasion of these parasites has been observed in Duffy-negative erythrocytes 
(Moon et al., 2013). The DBL protein of P. knowlesi, also known as the Duffy-binding 
protein (PkDBPα), interacted with DARC and is divided into seven domains (I-VII). 
PkDBPαII contains the critical motifs for binding to Duffy-positive human and 
macaque erythrocytes (Moon et al., 2016; Lim et al., 2017). The levels of DARC on 
mature erythrocytes are reduced compared with that on reticulocytes (Moon et al., 
2013), indicating the predilection of these parasites for reticulocytes.  
 
2.3.6 Cultivation of P. knowlesi 
 
2.3.6(a) In vivo cultivation of P. knowlesi 
 
P. knowlesi was first isolated from M. fascicularis in 1932 (Sinton and 
Mulligan, 1933). Many laboratory P. knowlesi strains such as Nuri strain isolated from 
M. irus in 1932 (Edeson and Davey, 1953), Hackeri strain isolated from A. hackeri in 
1961 (Wharton and Eyles, 1961) and H strain isolated from the first infected human in 
1965 (Chin et al., 1965) have been established and subcultured in rhesus macaques 
(Butcher and Mitchell, 2018; Galinski and Barnwell, 2012). Many types of macaques 
such as M. mulatta (Collins et al., 1971), M. radiate (Dutta et al., 1982), M. assamensis 
(Dutta et al., 1978), Presbytis entellus (Dutta et al., 1981), Saimiri sciureus (Collins et 
al., 1978) and Aotus trivigatus (Garnham, 1966) have been utilised for in vivo culture. 
Although in vivo models using macaques as a host for P. knowlesi have been a valuable 




considerations. These limitations caused restrictions for research on animal models 
(Grüring et al., 2014).  
 
2.3.6(b) In vitro cultivation of P. knowlesi 
 
Although the establishment of continuous in vitro culture systems for P. 
knowlesi is a challenge, it will avoid reliance on in vivo protocols (Chua et al., 2019). 
The first in vitro culture using rhesus erythrocytes was successfully performed in 1945; 
however, P. knowlesi could only be cultured for up to six intraerythrocytic cycles (Ball 
et al., 1945). Improvements were made and the parasite was able to be cultured for 
several months with frequent media change (Butcher, 1979; Wickham et al., 1980). In 
2002, the H strain of P. knowlesi was cultured continuously (Kocken et al., 2002); 
however, the requirement for rhesus erythrocytes restricted the research to a laboratory 
with the access of macaque blood (Kocken et al., 2009). This suggests the need for P. 
knowlesi lines that can grow exclusively in human blood in vitro. A successful 
adaptation of the P. knowlesi H strain (A1-H.1 line) to grow in human erythrocytes 
was achieved in 2013 (Lim et al., 2013; Moon et al., 2013). The invasion of this 
parasite line is highly dependent on DARC (Moon et al., 2013). A further study on the 
exact receptors involved in the later stage of invasion is required since the levels of 
DARC reduced as the erythrocytes mature (Grüring et al., 2014).  
 
It has been reported that the target cells for P. knowlesi in the natural host 
macaques were not restricted to cells of a certain age, which the parasite can invade 
both mature erythrocytes called normocytes and young erythrocytes called 




parasite mainly invades reticulocytes (Ball et al., 1945; Grüring et al., 2014). P. 
knowlesi also showed a poor ability to multiply in human erythrocytes and a decreased 
invasion efficiency for mature erythrocytes (Lim et al., 2013; Mohamad and Abu-
Bakar, 2019). This is due to the decrease DARC levels on mature erythrocytes 
compared to reticulocytes (Moon et al., 2013). The preference of P. knowlesi towards 
reticulocytes becomes a major concern towards the establishment of an in vitro culture 
(Lim et al., 2013; Grüring et al., 2014). Therefore, there is a considerable research 
interest in generating enough Duffy-positive reticulocytes for P. knowlesi in vitro 
culture using a variety of sources including stem cells. 
 
2.4 Stem cells 
 
2.4.1 Unique characteristics of stem cells 
 
Stem cells are unspecialised cells characterised by the unique ability to 
self-renewal and have potential to differentiate into multiple specialised cell types 
(Mariniello et al., 2019). The cells are able to undergo unlimited self-renewal through 
symmetric cell division to maintain a pool of undifferentiated cells while also giving 
rise to differentiated daughter cells via asymmetric division (Łos et al., 2019). 
Additionally, the cells are unspecialised cells in which it lacks tissue-specific 
structures that allow it to perform specialised functions. However, unspecialised stem 
cells are able to give rise to specialised cells such as heart muscle cells, nerve cells and 
blood cells via a differentiation process under defined physiological and experimental 
conditions (Slack, 2018). These properties make stem cells an attractive cell source for 
clinical and malaria research applications.  
